Which patients could benefit from early biologic therapy for rheumatoid arthritis?


In all, Alenius et al. recruited 102 healthy controls, 306 patients with psoriasis (160 with arthritis and 146 without), and 101 patients with early RA. As expected, the prevalence of anti-CCP antibodies was highest in patients with early RA (74%). Among patients with psoriasis, those with arthritis had a higher prevalence of anti-CCP antibodies than those… (More)
DOI: 10.1038/ncprheum0184


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics